Literature DB >> 29243131

Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

Danijela Karalic1, Ivana Lazarevic2, Ana Banko2, Maja Cupic2, Djordje Jevtovic3, Tanja Jovanovic2.   

Abstract

In immunocompromised individuals, especially in patients with T cell immunodeficiency, reactivation of JCPyV can cause serious life-threatening diseases. Nowadays, HIV infection is one of the most important factor for reactivation of JCPyV and the development of of the progressive multifocal leukoencephalopathy (PML). Mutations in the outer loops of the VP1 region can lead to the selection of the viral variants with changed tropism and increased pathological potential. The aims of this study were to determine sequence variation and amino acid changes within VP1 loops and the structure of non-coding control region (NCCR) of urinary excreted JCPyV isolates among HIV-infected patients and healthy donors. Single urine samples from 114 HIV-infected patients and 120 healthy donors were collected. PCR was performed for amplification of VP1 and NCCR. Amplified fragments were directly sequenced and analyzed by using bioinformatics tools. Nucleotide substitutions were detected within DE and EF loops and in the β-sheets of both studied groups. In HIV-infected patients group, 70% of mutations were detected within receptor domains. Among healthy donors, one mutation was identified within β-sheets while the remaining were located within receptor domains. The most prevalent mutation was L157V in both groups. Analysis of NCCR revealed that all isolates had archetype structure with some minor changes. Since single point mutations at specific place within outer loop of VP1 region can cause formation of variants with changed receptor specificity, identification of these mutations in HIV-infected patients can help to single out those with higher risk for development of polyomavirus-associated diseases.

Entities:  

Keywords:  HIV; JC polyomavirus; Mutations; Regulatory region; VP1

Mesh:

Substances:

Year:  2017        PMID: 29243131     DOI: 10.1007/s13365-017-0608-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  45 in total

1.  Genotypes of JC virus in East, Central and Southwest Europe.

Authors:  Hansjürgen T Agostini; Alison Deckhut; David V Jobes; Rosina Girones; Günther Schlunck; Marcin G Prost; Carolina Frias; E Pérez-Trallero; Caroline F Ryschkewitsch; Gerald L Stoner
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

2.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

3.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 4.  Pathogenesis of progressive multifocal leukoencephalopathy--revisited.

Authors:  Martyn K White; Kamel Khalili
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

Review 5.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

Review 6.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

7.  Characterization of JC human polyomavirus infection in a Portuguese population.

Authors:  Ana Matos; Vitor Duque; Sílvia Beato; João Poiares da Silva; Eugene Major; António Meliço-Silvestre
Journal:  J Med Virol       Date:  2010-03       Impact factor: 2.327

8.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

9.  Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Authors:  P M Chesters; J Heritage; D J McCance
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML).

Authors:  Shamil R Sunyaev; Alexey Lugovskoy; Kenneth Simon; Leonid Gorelik
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  2 in total

1.  Database and Statistical Analyses of Transcription Factor Binding Sites in the Non-Coding Control Region of JC Virus.

Authors:  Kazuo Nakamichi; Toshio Shimokawa
Journal:  Viruses       Date:  2021-11-19       Impact factor: 5.048

Review 2.  The oncogenic roles of JC polyomavirus in cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.